Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020

SELL
$0.33 - $1.62 $4,155 - $20,400
-12,593 Reduced 30.82%
28,272 $26,000
Q4 2019

Feb 14, 2020

BUY
$1.23 - $2.67 $15,489 - $33,623
12,593 Added 44.54%
40,865 $64,000
Q3 2019

Nov 07, 2019

BUY
$1.25 - $5.0 $35,340 - $141,360
28,272 New
28,272 $61,000
Q2 2019

Aug 12, 2019

SELL
$1.65 - $6.72 $48,064 - $195,753
-29,130 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$4.84 - $9.07 $57,024 - $106,862
11,782 Added 67.92%
29,130 $204,000
Q4 2018

Feb 11, 2019

BUY
$4.21 - $14.28 $73,035 - $247,729
17,348 New
17,348 $108,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $798M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.